Autism initiative embraces little-tested vitamin as a treatment

Puntos clave

• Leucovorin has gained FDA approval, raising important questions about its efficacy for autism treatment.
• This approval comes amid controversy regarding which patients may actually benefit from leucovorin's use.
• The initiative's focus on leucovorin reflects an attempt to explore alternative treatments for autism.
• The implications of this approval may encourage further research into the role of vitamins in autism care.